rs727505178
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_ModeratePP3_StrongPP5
The NM_001267550.2(TTN):c.19426+2T>A variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,453,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001267550.2 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.19426+2T>A | splice_donor_variant | ENST00000589042.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.19426+2T>A | splice_donor_variant | 5 | NM_001267550.2 | P1 | |||
TTN-AS1 | ENST00000659121.1 | n.503-6006A>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1453496Hom.: 0 Cov.: 32 AF XY: 0.0000125 AC XY: 9AN XY: 721582
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 20, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 06, 2017 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2J Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 15, 2022 | Variant summary: TTN c.15694+2T>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Three computational tools predict the variant abolishes a 5' splicing donor site, and one publication has confirmed via cDNA sequencing that this variant causes exon skipping (Savarese_2020). The variant was absent in 242840 control chromosomes (gnomAD). Individuals affected with TTN-related myopathies that were heterozygous for c.15694+2T>A and for another causative TTN variant (confirmed compound heterozygous in at least two occasions), have been reported in the literature (Savarese_2020, Rees_2021, Natera-de Benito_2021, Salih_2021). These data indicate that the variant is likely to be associated with disease. One ClinVar submitter assessed the variant after 2014 (but before the studies utilized in this ascertainment were published), and classified it as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Dilated cardiomyopathy 1G Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 29, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 05, 2014 | Variant classified as Uncertain Significance - Favor Pathogenic. The 15694+2T>A variant in TTN has not been previously reported in the literature or in large po pulation studies. This variant occurs in the invariant region (+/- 1,2) of the s plice consensus sequence and is predicted to cause altered splicing leading to a n abnormal or absent protein. Variants in TTN have been reported in several type s of myopathy including both dominant and recessive forms, and truncating varian ts (such as this variant) in particular have been implicated in autosomal recess ive centronuclear myopathy (Haravuori 2001, Hackman 2002, Lange 2005, Carmignac 2007, Hackman 2008, Ohlsson 2012, Pfeffer 2012, Ceyhan-Birsoy 2013). In addition , splice and other truncating variants in TTN are strongly associated with DCM, particularly if they are located in the exons encoding for the A-band region of the protein (Herman 2012, Pugh 2014). Variants in the I-band, where with variant is located, occur at a greater frequency in controls than in individuals with D CM (Pugh 2014), which decreases (but does not rule out) that this variant has a role in DCM. In summary, while there is some suspicion for a pathogenic role for myopathy and cardiomyopathy, based upon the arguments described above, the clin ical significance of the 15694+2T>A variant is uncertain. - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 09, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is located in the I band of TTN (PMID: 25589632). Truncating variants in this region have been shown to be highly prevalent in the general population and unaffected individuals (PMID: 26701604, 22335739). However, truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 179861). Disruption of this splice site has been observed in individuals with clinical features of TTN-related conditions and/or limb-girdle muscular dystrophy (PMID: 32528171, 33333461, 34918981; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 66 of the TTN gene. It is expected to disrupt RNA splicing and likely results in a truncated or disrupted TTN protein. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at